Drugs / 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
13-valent pneumococcal conjugate vaccine (multivalent conjugate)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05759520 | Nov 2022 → Jun 2025 overdue | pneumococcal infection | Fosun Adgenvax Biopharmaceutical Co.,Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13-valent pneumococcal conjugate vaccine (multivalent conjugate) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05759520 ↗ |
| Modality | Vaccine | “13-valent pneumococcal conjugate vaccine (multivalent conjugate)” NCT05759520 ↗ |